CI
Wall Street’s vibe check: slightly less enthusiastic
Robert W. Baird took a small haircut to Cigna’s price target, dropping it from $315 to $306, but didn’t go full doom-and-gloom. The firm kept its Outperform rating, which is basically the analyst version of saying, “I’m still in, I just lost a little swagger.”
The real story isn’t the haircut
For investors, the bigger takeaway is that the target cut came in the middle of a pretty solid backdrop. Cigna just said quarterly EPS came in at $8.08, ahead of the $7.88 estimate, and revenue hit $72.5 billion versus expectations for $69.53 billion. Not exactly the kind of numbers that make you reach for the panic button.
The company also set FY2026 guidance at 30.250 EPS, which helps explain why the broader analyst crowd still sounds constructive. The average Street target is sitting at $332.63, with some folks reaching even higher.
What you should care about
This kind of note matters because price targets can nudge sentiment, even when the underlying business is humming. If you own Cigna, the message is basically: Wall Street still likes the stock, but after a strong run, some analysts are dialing down the upside math a bit.
Big picture: Cigna isn’t getting punished here — it’s getting lightly side-eyed. And in analyst land, that’s usually a pretty decent place to be.